In vitro activity of ceftobiprole against Gram-positive and Gram-negative bacteria isolated from humans and animals

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 4, 2010, Pages 801-803

  Silva, Nuno ^a,b   Radhouani, Hajer ^a,b   Gonçalves, Alexandre ^a,b   Araújo, Carlos ^a,b   Rodrigues, Jorge ^a,b   Igrejas, Gilberto ^a   Poeta, Patrícia ^a,b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Cefepime; E. coli; Enterococci; ESBL containing E. coli strains; MRSA; MSSA

Indexed keywords

CEFEPIME; CEFTOBIPROLE; CEFTOBIPROLE MEDOCARIL; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FECES CULTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; LETTER; METHICILLIN RESISTANT COAGULASE NEGATIVE STAPHYLOCOCCI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANT STREPTOCOCCUS PNEUMONIAE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; STAPHYLOCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 77952572805     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq011     Document Type: Letter

References (6)

1. Chambers HF. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clin Microbiol Infect 2006; 12 Suppl 2: 17-22.
2. Fritsche TR, Sader HS, Jones RN. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Diagn Microbiol Infect Dis 2008; 61: 86-95.
3. Pillar CM, Aranza MK, Shah D et al. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin. J Antimicrob Chemother 2008; 61: 595-602.
4. Noel GJ, Strauss RS, Amsler K et al. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrob Agents Chemother 2008; 52: 37-44.
5. Poeta P, Costa D, Rodrigues J et al. Antimicrobial resistance and the mechanisms implicated in faecal enterococci from healthy humans, poultry and pets in Portugal. Int J Antimicrob Agents 2006; 27: 131-7.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement: M100-S17. CLSI, Wayne, PA, USA, 2007.